Recall Alert: Airsupra Inhalers Recalled for Defective Delivery System
AstraZenca is recalling more than 1 million inhalers for a defective delivery system. Recalled inhalers
AstraZenca is recalling more than 1 million inhalers for a defective delivery system. Recalled inhalers
The “theme” of the 2025 GINA Strategy is “Make Inhaled Treatments Accessible for ALL.” “Doctors
Join the American Medical Journal’s AMJ Podcast for this two-episode mini-series featuring lead study authors,
The 2025 Data Dashboard Release Schedule is now available for INHALE members. You can find
Maintenance Notice: The INHALEarning platform is under maintenance from 02/04/2025 to 2/10/2025. For immediate concerns,
Dr. Njira Lugogo, Primary Investigator at MI Asthma Research, discusses asthma related deaths in Detroit
Public Health Bulletin for Health Care – January 2025 The Michigan Department of Health &
This toolkit contains a variety of resources to assist providers in understanding pulmonary rehabilitation. We encourage
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) released its 2025 updated version of
Pulmonary function testing is the gold standard set by the American Thoracic Society to diagnose
INHALE prepares regular PO and Clinical level newsletters that contain:
Arbor Lakes Building 3, Floor 3
4251 Plymouth Rd.
Ann Arbor, MI 48105
Support for the INHALE CQI is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs.
Although Blue Cross Blue Shield of Michigan and the INHALE CQI work in partnership, the opinions, beliefs, and viewpoints expressed by INHALE CQI do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.